CELYAD SA by Celyad Oncology SA (CLYYF) Stock Price, Quote, News & History

Key Statistics

Open

Volume / Avg.

0 / 1.98K

Day Range

- - -

52 Wk Range

0.15 - 0.35

Market Cap

P/E Ratio

13.42

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

11.71

Recent Celyad Oncology SA News

Stocks That Hit 52-Week Lows On Tuesday

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-6.90M

Investing Cash Flow (TTM)

3.01M

Financing Cash Flow (TTM)

1.39M

Free Cash Flow (TTM)

-6.90M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-2.50M

Valuation Metrics

Enterprise Value

$13.06M

PE Ratio (TTM)

13.42

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

530.54

PB Ratio (TTM)

4.69

Earnings Yield % (TTM)

7.45%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

10.55

Price / EBITDA (TTM)

10.45

Price / Free Cash Flow (TTM)

Book Value / Share

$0.06

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$1.71M

Debt to Equity

0.00

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

Volume / Avg.

0 / 1.98K

Day Range

- - -

52 Wk Range

0.15 - 0.35

Market Cap

P/E Ratio

13.42

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

11.71

About

Sector

Health Care

Industry

Biotechnology

Celyad Oncology SA is a biopharmaceutical company focused on the discovery and development of technologies for chimeric antigen receptor T-cell (CAR T) therapies. The company focuses on solid tumors and hematological malignancies. The firm has CYAD-0...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

CLYYF

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

CLYYF

FAQ

How do I buy CELYAD SA by Celyad Oncology SA (CLYYF) stock?

You can purchase shares of CELYAD SA by Celyad Oncology SA (OTCEM:CLYYF) through any online brokerage.

View our list of the best stock brokerages

Who are CELYAD SA by Celyad Oncology SA (CLYYF) competitors?

There are no as such competitors for CELYAD SA by Celyad Oncology SA.

What is the forecast, or price target, for CELYAD SA by Celyad Oncology SA (CLYYF) stock?

There is no analysis for CELYAD SA by Celyad Oncology SA to provide a consensus price target.

What is the current price for CELYAD SA by Celyad Oncology SA (CLYYF)?

The stock price for CELYAD SA by Celyad Oncology SA (OTCEM: CLYYF) is $0.28 last updated August 7, 2026 at 1:29 PM EDT.

Does CELYAD SA by Celyad Oncology SA (CLYYF) pay a dividend?

There are no upcoming dividends for CELYAD SA by Celyad Oncology SA.

When is CELYAD SA by Celyad Oncology SA (OTCEM:CLYYF) reporting earnings?

CELYAD SA by Celyad Oncology SA does not have any upcoming earnings scheduled.

Is CELYAD SA by Celyad Oncology SA (CLYYF) going to split?

There is no upcoming split for CELYAD SA by Celyad Oncology SA.

What sector and industry does CELYAD SA by Celyad Oncology SA (CLYYF) operate in?

CELYAD SA by Celyad Oncology SA is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.